title: [Transluminal percutaneous angioplasty of stenosis of arteriovenous fistulas; 24-month follow-up].
abstract: Stenosis is a common cause of the functional loss of vascular shunts used in chronic hemodialysis and percutaneous transluminal angioplasty represents the elective method to correct these anomalies. A total of 42 percutaneous transluminal angioplasties were performed, with a prospective study and follow-up lasting an average of 18 months, in 32 patients with insufficient blood flow of arteriovenous fistula. In over 90% of cases the procedure restored adequate hemodynamic conditions that remained unchanged during follow-up. The authors therefore conclude that percutaneous transluminal angioplasty is an efficacious, easily performed and low-cost method that does not present major complications.
authors.affiliation: Azienda Ospedaliera S.S. Antonio e Biagio e C. Arrigo, Alessandria.
authors.forename: A
authors.initials: A
authors.lastname: Ortensia
authors.forename: G
authors.initials: G
authors.lastname: Carosio
authors.forename: M
authors.initials: M
authors.lastname: Iberti
authors.forename: M
authors.initials: M
authors.lastname: Reale
authors.forename: M
authors.initials: M
authors.lastname: Della Volpe
authors.forename: G
authors.initials: G
authors.lastname: Taverna
authors.forename: G
authors.initials: G
authors.lastname: Veronesi
authors.forename: G
authors.initials: G
authors.lastname: Balestrero
mesh_terms: D000328:Adult; D000368:Aged; D001166:Arteriovenous Shunt, Surgical; D016121:Brachiocephalic Veins / Q000601:surgery; D002404:Catheterization / Q000191:economics / Q000379:methods*; D003251:Constriction, Pathologic / Q000628:therapy; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017534:Radial Artery / Q000601:surgery; D006435:Renal Dialysis / Q000295:instrumentation / Q000379:methods*; D016896:Treatment Outcome
vernacular_title: Angioplastica percutanea transluminare delle stenosi di fistole artero-venose. Follow-up di 24 mesi.